135 related articles for article (PubMed ID: 1450848)
1. Preliminary results of concurrent cisplatin and radiation therapy in locally advanced bladder cancer.
Utsunomiya M; Itoh H; Yoshioka T; Masaki N; Itatani H
Br J Urol; 1992 Oct; 70(4):399-403. PubMed ID: 1450848
[TBL] [Abstract][Full Text] [Related]
2. Combined intraarterial cisplatin infusion and radiation therapy for invasive bladder cancer.
Mizoguchi H; Nomura Y; Terada K; Nakagawa M; Ogata J
Int J Urol; 1995 Mar; 2(1):17-23. PubMed ID: 7614405
[TBL] [Abstract][Full Text] [Related]
3. Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients.
Kageyama Y; Okada Y; Arai G; Hyochi N; Suzuki M; Masuda H; Hayashi T; Kawakami S; Okuno T; Ishizaka K; Kihara K
Jpn J Clin Oncol; 2000 Dec; 30(12):553-6. PubMed ID: 11210165
[TBL] [Abstract][Full Text] [Related]
4. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
[TBL] [Abstract][Full Text] [Related]
5. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
[TBL] [Abstract][Full Text] [Related]
7. Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer.
Chen WC; Liaw CC; Chuang CK; Chen MF; Chen CS; Lin PY; Chang PL; Chu SH; Wu CT; Hong JH
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):726-33. PubMed ID: 12788178
[TBL] [Abstract][Full Text] [Related]
8. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution.
Peyromaure M; Slama J; Beuzeboc P; Ponvert D; Debré B; Zerbib M
Urology; 2004 Jan; 63(1):73-7. PubMed ID: 14751352
[TBL] [Abstract][Full Text] [Related]
10. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.
Housset M; Maulard C; Chretien Y; Dufour B; Delanian S; Huart J; Colardelle F; Brunel P; Baillet F
J Clin Oncol; 1993 Nov; 11(11):2150-7. PubMed ID: 8229129
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer.
Caffo O; Fellin G; Graffer U; Valduga F; Bolner A; Luciani L; Tomio L; Galligioni E
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1310-6. PubMed ID: 14630267
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results of simultaneous radiochemotherapy with paclitaxel for urinary bladder cancer.
Dunst J; Weigel C; Heynemann H; Becker A
Strahlenther Onkol; 1999 Oct; 175 Suppl 3():7-10. PubMed ID: 10554638
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of chemotherapy alternating with twice-a-day accelerated radiation therapy as an alternative to cystectomy in muscle infiltrating (stages T2 and T3) cancer of the bladder: preliminary results.
Vikram B; Malamud S; Silverman P; Hecht H; Grabstald H
J Urol; 1994 Mar; 151(3):602-4. PubMed ID: 8308967
[TBL] [Abstract][Full Text] [Related]
15. Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study.
Fellin G; Graffer U; Bolner A; Ambrosini G; Caffo O; Luciani L
Br J Urol; 1997 Jul; 80(1):44-9. PubMed ID: 9240179
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
Gogna NK; Matthews JH; Turner SL; Mameghan H; Duchesne GM; Spry N; Berry MP; Keller J; Tripcony L;
Radiother Oncol; 2006 Oct; 81(1):9-17. PubMed ID: 17011058
[TBL] [Abstract][Full Text] [Related]
17. RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.
Hagan MP; Winter KA; Kaufman DS; Wajsman Z; Zietman AL; Heney NM; Toonkel LM; Jones CU; Roberts JD; Shipley WU
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):665-72. PubMed ID: 14529770
[TBL] [Abstract][Full Text] [Related]
18. The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.
Serretta V; Lo Greco G; Pavone C; Pavone-Macaluso M
J Urol; 1998 Apr; 159(4):1187-91. PubMed ID: 9507829
[TBL] [Abstract][Full Text] [Related]
19. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
Hussain MH; Glass TR; Forman J; Sakr W; Smith DC; Al-Sarraf M; Jones J; Balcerzak SP; Crawford ED; Grossman HB
J Urol; 2001 Jan; 165(1):56-60; discussion 60-1. PubMed ID: 11125363
[TBL] [Abstract][Full Text] [Related]
20. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
